老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

1.47
+0.04002.80%
成交量：12.68萬
成交額：18.01萬
市值：1.46億
市盈率：-0.90
高：1.48
開：1.43
低：1.37
收：1.43
資料載入中...
總覽公司新聞公告
2021/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
更多